Pekka Kolehmainen
PhD
pekka.j.kolehmainen@utu.fi Office: D7020 ORCID identifier: https://orcid.org/0000-0001-5997-8167 |
Areas of expertise
RNA viruses, molecular virology, virological methods
RNA viruses, molecular virology, virological methods
Publications
- Nucleocapsid protein enhances spike- and RBD-specific humoral and cellular immune responses in protein-based SARS-CoV-2 vaccine (2026)
- BMC Infectious Diseases
(A1 Refereed original research article in a scientific journal) - Influenza A(H5N8) vaccine induces humoral and cell-mediated immunity against highly pathogenic avian influenza clade 2.3.4.4b A(H5N1) viruses in at-risk individuals (2025)
- Nature Microbiology
(A1 Refereed original research article in a scientific journal) - Long-term neutralization capacity of vaccine and breakthrough infection induced SARS-CoV-2 specific antibodies against omicron subvariants BA.2, XBB.1.5, and JN.1 (2025)
- Vaccine
(A1 Refereed original research article in a scientific journal) - Long-term COVID-19 vaccine- and Omicron infection-induced humoral and cell-mediated immunity (2024)
- Frontiers in immunology
(A1 Refereed original research article in a scientific journal) - Neutralizing antibodies after the third COVID-19 vaccination in healthcare workers with or without breakthrough infection (2024)
- Communications medicine
(A1 Refereed original research article in a scientific journal) - The comprehensive SARS-CoV-2 ‘hijackome’ knowledge base (2024)
- Cell Discovery
(A1 Refereed original research article in a scientific journal) - Virus-specific Dicer-substrate siRNA swarms inhibit SARS-CoV-2 infection in TMPRSS2-expressing Vero E6 cells (2024)
- Frontiers in microbiology
(A1 Refereed original research article in a scientific journal) - Coronavirus spike protein-specific antibodies indicate frequent infections and reinfections in infancy and among BNT162b2-vaccinated healthcare workers (2023)
- Scientific Reports
(A1 Refereed original research article in a scientific journal) - COVID-19 adenovirus vector vaccine induces higher interferon and pro-inflammatory responses than mRNA vaccines in human PBMCs, macrophages and moDCs (2023)
- Vaccine
(A1 Refereed original research article in a scientific journal) - Image-based and machine learning-guided multiplexed serology test for SARS-CoV-2 (2023)
- Cell reports : methods
(A1 Refereed original research article in a scientific journal)



